Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Nathanson

Showing results (81-90 of 528) with videos related to

Pageof 53
Sort By:
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 1, 1992
12-O-tetradecanoylphorbol-13-acetate induces transient cell cycle arrest in G1 and G2 in metastatic melanoma cells: inhibition of phosphorylation of p34cdc2D L Coppock, J B Tansey, L Nathanson
Cancer|March 1, 1979
High dose methotrexate with and without BCG therapy in advanced head and neck malignancyM Buechler, B Mukherji, W Chasin, et al.
Cancer Research|May 1, 1984
Effect of triamcinolone acetonide on tyrosinase activity in a human melanoma cell lineD M DiSorbo, N A Harris, L Nathanson
American Family Physician|August 1, 1984
Halo nevi and melanomaJ R Pellegrini, R F Wagner, L Nathanson
International Journal of Dermatology|September 1, 1984
Nutrition and melanomaR F Wagner, D M DiSorbo, L Nathanson
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1980
Spontaneous in vitro cytotoxicity against autochthonous human melanoma cellsB Mukherji, A Flowers, L Rothman, et al.
Science (New York, N.Y.)|March 29, 2014
Two decades after BRCA: setting paradigms in personalized cancer care and preventionFergus J Couch, Katherine L Nathanson, Kenneth Offit
Cancer|September 15, 1981
Vinblastine, infusion, bleomycin, and cis-dichlorodiammine-platinum chemotherapy in metastatic melanomaL Nathanson, S D Kaufman, R W Carey
Cancer|March 15, 1981
Radiation therapy of malignant melanomas: an evaluation of clinically used fractionation schemesA Strauss, A Dritschilo, L Nathanson, et al.
Cancer Research|January 1, 1974
Heterotransplantation model of human malignant melanomaB Mukherji, A Flowers, L Nathanson, et al.
Pageof 53

Showing results (81-90 of 528) with videos related to

Sort By:
Pageof 53
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 1, 1992
12-O-tetradecanoylphorbol-13-acetate induces transient cell cycle arrest in G1 and G2 in metastatic melanoma cells: inhibition of phosphorylation of p34cdc2D L Coppock, J B Tansey, L Nathanson
Cancer|March 1, 1979
High dose methotrexate with and without BCG therapy in advanced head and neck malignancyM Buechler, B Mukherji, W Chasin, et al.
Cancer Research|May 1, 1984
Effect of triamcinolone acetonide on tyrosinase activity in a human melanoma cell lineD M DiSorbo, N A Harris, L Nathanson
American Family Physician|August 1, 1984
Halo nevi and melanomaJ R Pellegrini, R F Wagner, L Nathanson
International Journal of Dermatology|September 1, 1984
Nutrition and melanomaR F Wagner, D M DiSorbo, L Nathanson
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1980
Spontaneous in vitro cytotoxicity against autochthonous human melanoma cellsB Mukherji, A Flowers, L Rothman, et al.
Science (New York, N.Y.)|March 29, 2014
Two decades after BRCA: setting paradigms in personalized cancer care and preventionFergus J Couch, Katherine L Nathanson, Kenneth Offit
Cancer|September 15, 1981
Vinblastine, infusion, bleomycin, and cis-dichlorodiammine-platinum chemotherapy in metastatic melanomaL Nathanson, S D Kaufman, R W Carey
Cancer|March 15, 1981
Radiation therapy of malignant melanomas: an evaluation of clinically used fractionation schemesA Strauss, A Dritschilo, L Nathanson, et al.
Cancer Research|January 1, 1974
Heterotransplantation model of human malignant melanomaB Mukherji, A Flowers, L Nathanson, et al.
Pageof 53